{}
Our News
John Maraganore Named to Bloomberg 50 List for 2018
December 11, 2018
Alnylam Pharmaceuticals
Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018. He and Spark Therapeutics CEO Jeff Marrazzo were deemed "the gene medicine revolutionaries" for leading companies that introduced the first groundbreaking genetic treatments derived from the mapping of the human genome.
Click here to read the article on the Bloomberg website.
FOLLOW US
